How nanotechnology imaging can be used in kidney disease: An interview with Dr Mengxiao Yu

Abstract

Author biography Dr Yu currently is a research assistant professor at University of Texas at Dallas and is the Chief Scientist and Chief Executive Officer of ClearNano, Inc. She received her B.S. in Chemistry from Beijing Normal University in China in 2004, and her PhD in Chemistry from Fudan University in 2009. After that she joined Dr Jie Zheng's group at University of Texas at Dallas as a postdoctoral fellow and was promoted to research scientist in 2014 and research assistant professor in 2015. Her current research area comprises renal nanomedicine, biomedical imaging, luminescent gold nanoparticles and kidney disease detection.